Company / Shares Outstanding
Sarepta Therapeutics Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
96.9M
FY2025
5-year range
79.4M / 96.9M
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
#101 of 212
Health Care
What the data says
At 96900496.00, Sarepta Therapeutics's shares outstanding ranks #112 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 45629529.00 in FY2016 to 96900496.00 in FY2025.
Based on SEC 10-K filings.
96900496.00 in FY2025 with a 5-year CAGR of +5.2%.
Increased from 87950117.00 to 96900496.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +5.2%
- 10-Year CAGR
- -
Sector benchmark
#112 of 212 in Health CareTop 52% of 212This company 96.9M Sector average 306.7M
▼
-68.4% below sector average
Key checks
Key Insights
- Sarepta Therapeutics's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 3.4% year-over-year.
- Ranks #101 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 96.9M | +3.4% |
| FY2024 | 93.7M | +6.6% |
| FY2023 | 88.0M | +0.9% |
| FY2022 | 87.1M | +9.8% |
| FY2021 | 79.4M | +5.6% |
| FY2020 | 75.2M | +5.8% |
| FY2019 | 71.1M | +9.7% |
| FY2018 | 64.8M | +18.3% |
| FY2017 | 54.8M | +20.0% |
| FY2016 | 45.6M | +7.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026